CoChat

Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics

Open access

The DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index.

Abstract

Many cellular proteins assemble into macromolecular protein complexes. The identification of protein-protein interactions and quantification of their stoichiometry is therefore crucial to understand the molecular function of protein complexes. Determining the stoichiometry of protein complexes is usually achieved by mass spectrometry-based methods that rely on introducing stable isotope-labeled reference peptides into the sample of interest. However, these approaches are laborious and not suitable for high-throughput screenings. Here, we describe a robust and easy to implement label-free relative quantification approach that combines the detection of high-confidence protein-protein interactions with an accurate determination of the stoichiometry of the identified protein-protein interactions in a single experiment. We applied this method to two chromatin-associated protein complexes for which the stoichiometry thus far remained elusive: the MBD3/NuRD and PRC2 complex. For each of these complexes, we accurately determined the stoichiometry of the core subunits while at the same time identifying novel interactors and their stoichiometry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gks941

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Stoichiometry of protein complexes revealed by label-free quantitative proteomics. (A) Nuclear extracts from BAC-GFP transgenic cell lines and HeLa WT cells are subjected to single-step GFP-affinity enrichment using GFP trap beads in triplicate (ipGFP and cWT, respectively). As an additional control, BAC-GFP cell line nuclear extract is incubated with beads lacking GFP binder in triplicate (cBEAD). Thus, nine separate pull-downs are performed and each of these is separately analyzed by LC-MS/MS. (B) Statistically enriched proteins in the GFP-BAC IP are identified by permutation-based FDR-corrected t-test. The LFQ intensity of the GFP pull-down over the control is plotted against the–log 10 (P-value) and the red line indicates the permutation-based FDR threshold. The proteins in the upper right corner represent the bait and its interactors. (C) Stoichiometry of the interactors is determined by calculating the iBAQ intensities. Since the iBAQ values obtained in the control samples (cBEAD and cWT) indicate background binding, these iBAQ intensities are subtracted from the iBAQ intensity in the GFP pull-down [iBAQ (ipGFP-cBEAD); x-axis and iBAQ (ipGFP-cWT); y-axis]. The remaining values were scaled according to the abundance of the bait protein, resulting in the stoichiometry of the interactors relative to the bait.
Figure 1. Stoichiometry of protein complexes revealed by label-free quantitative proteomics. (A) Nuclear extracts from BAC-GFP transgenic cell lines and HeLa WT cells are subjected to single-step GFP-affinity enrichment using GFP trap beads in triplicate (ipGFP and cWT, respectively). As an additional control, BAC-GFP cell line nuclear extract is incubated with beads lacking GFP binder in triplicate (cBEAD). Thus, nine separate pull-downs are performed and each of these is separately analyzed by LC-MS/MS. (B) Statistically enriched proteins in the GFP-BAC IP are identified by permutation-based FDR-corrected t-test. The LFQ intensity of the GFP pull-down over the control is plotted against the–log 10 (P-value) and the red line indicates the permutation-based FDR threshold. The proteins in the upper right corner represent the bait and its interactors. (C) Stoichiometry of the interactors is determined by calculating the iBAQ intensities. Since the iBAQ values obtained in the control samples (cBEAD and cWT) indicate background binding, these iBAQ intensities are subtracted from the iBAQ intensity in the GFP pull-down [iBAQ (ipGFP-cBEAD); x-axis and iBAQ (ipGFP-cWT); y-axis]. The remaining values were scaled according to the abundance of the bait protein, resulting in the stoichiometry of the interactors relative to the bait.CC BY-NC · PubMed Central
Figure 2. Benchmarking the method using the PRP19/CDC5L spliceosomal complex. (A) Significant interactors of CDC5L–GFP are identified by permutation-based FDR-corrected t-test (threshold: P = 0.0001 and S0 = 0.4). The LFQ intensity of the GFP pull-down over the control is plotted against the −log 10 (P-value). The red line indicates the permutation-based FDR threshold. (B and C) Stoichiometry determination for the 11 most abundant and statistically significant CDC5L–GFP interactors. The abundance of the interactors in the specific pull-down (iBAQ value) was corrected for the obtained abundance in the control pull-downs: iBAQ (ipGFP-cBEAD) [x-axis (b) or grey bar(c)] and iBAQ (ipGFP-cWT) [y-axis (b) or black bar (c)] pull-down. The remaining values were scaled according to the abundance of the bait protein (CDC5L–GFP, green), which was set to 1. Error bars indicate the SD in the triplicate pull-downs.
Figure 2. Benchmarking the method using the PRP19/CDC5L spliceosomal complex. (A) Significant interactors of CDC5L–GFP are identified by permutation-based FDR-corrected t-test (threshold: P = 0.0001 and S0 = 0.4). The LFQ intensity of the GFP pull-down over the control is plotted against the −log 10 (P-value). The red line indicates the permutation-based FDR threshold. (B and C) Stoichiometry determination for the 11 most abundant and statistically significant CDC5L–GFP interactors. The abundance of the interactors in the specific pull-down (iBAQ value) was corrected for the obtained abundance in the control pull-downs: iBAQ (ipGFP-cBEAD) [x-axis (b) or grey bar(c)] and iBAQ (ipGFP-cWT) [y-axis (b) or black bar (c)] pull-down. The remaining values were scaled according to the abundance of the bait protein (CDC5L–GFP, green), which was set to 1. Error bars indicate the SD in the triplicate pull-downs.CC BY-NC · PubMed Central
Figure 3. Stoichiometry of NuRD revealed by label-free quantitative proteomics. (A) Identification of specific interactors of MBD3-GFP by a permutation-based FDR-corrected t-test (threshold: P = 0.01 and S0 = 0.5). Layout as in Figure 2A. (B and C) Stoichiometry determination of the statistically significant interactors of MBD3-GFP. Layout as in (Figure 2B and C). (D) Western-blot analysis of MBD3-GFP affinity purification reveals that MBD3-GFP does not form multimers, as no endogenous MBD3 was detected in the GFP affinity purification. Nuclear extracts from MBD3-GFP and WT HeLa cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as well as an endogenous antibody to MBD3 (lower panel).
Figure 3. Stoichiometry of NuRD revealed by label-free quantitative proteomics. (A) Identification of specific interactors of MBD3-GFP by a permutation-based FDR-corrected t-test (threshold: P = 0.01 and S0 = 0.5). Layout as in Figure 2A. (B and C) Stoichiometry determination of the statistically significant interactors of MBD3-GFP. Layout as in (Figure 2B and C). (D) Western-blot analysis of MBD3-GFP affinity purification reveals that MBD3-GFP does not form multimers, as no endogenous MBD3 was detected in the GFP affinity purification. Nuclear extracts from MBD3-GFP and WT HeLa cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as well as an endogenous antibody to MBD3 (lower panel).CC BY-NC · PubMed Central
Figure 4. Stoichiometry of PRC2 revealed by label-free quantitative proteomics. (A) Identification of specific interactors of EED-GFP by a permutation-based FDR-corrected t-test (threshold: P = 0.01 and S0 = 0.5). Layout as in Figure 2A. (B and C) Stoichiometry determination of the statistically significant interactors of EED-GFP. Layout as in (Figure 2B and C). (D) Western-blot analysis of EED-GFP affinity purification reveals that EED-GFP does not form multimers, since no endogenous EED is detected in the GFP-EED affinity purification. Nuclear extracts from EED-GFP and WT HeLa cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as well as an endogenous antibody to EED (lower panel).
Figure 4. Stoichiometry of PRC2 revealed by label-free quantitative proteomics. (A) Identification of specific interactors of EED-GFP by a permutation-based FDR-corrected t-test (threshold: P = 0.01 and S0 = 0.5). Layout as in Figure 2A. (B and C) Stoichiometry determination of the statistically significant interactors of EED-GFP. Layout as in (Figure 2B and C). (D) Western-blot analysis of EED-GFP affinity purification reveals that EED-GFP does not form multimers, since no endogenous EED is detected in the GFP-EED affinity purification. Nuclear extracts from EED-GFP and WT HeLa cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as well as an endogenous antibody to EED (lower panel).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 258

Metadata

Authors
Smits, A. H., Jansen, P. W. T. C., Poser, I., Hyman, A. A., & Vermeulen, M.
Affiliations
University Medical Center Utrecht (NL)
Corresponding author
Vermeulen, Michiel
Venue
Nucleic Acids Research
Published
2012-10-12
Volume
41
Issue
1
Pages
e28-e28
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2108549889
Cited by
258
References
28
Citations by year
2026: 7 · 2025: 14 · 2024: 12 · 2023: 10 · 2022: 13 · 2021: 16 · 2020: 24 · 2019: 32 · 2018: 22 · 2017: 28 · 2016: 29 · 2015: 20 · 2014: 18 · 2013: 11 · 2012: 1
FWCI
7.06
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Leibniz-Gemeinschaft
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
protein complex stoichiometry, protein-protein interaction, polycomb repressive complex 2, interactome mapping, chromatin remodeling
MeSH terms
RNA Splicing Factors, Chromatin, Chromosomal Proteins, Non-Histone, DNA-Binding Proteins, HeLa Cells, Humans, Nuclear Proteins, Mass Spectrometry, RNA-Binding Proteins, Cell Cycle Proteins, Protein Subunits, Protein Interaction Mapping, Proteomics, DNA Repair Enzymes, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Polycomb Repressive Complex 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. https://app.cochat.ai/papers/10.1093/nar/gks941
The paper
Smits, A. H., Jansen, P. W. T. C., Poser, I., Hyman, A. A., & Vermeulen, M. (2013). Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic Acids Research. https://doi.org/10.1093/nar/gks941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.